Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 282-438-4 | CAS number: 84204-70-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From the 29th of March to the 19th of April, 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study conducted according to internationally accepted guideline
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.3 (Acute Toxicity (Dermal))
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
Test material
- Reference substance name:
- Trisodium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]cobaltate(3-)
- EC Number:
- 282-438-4
- EC Name:
- Trisodium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]cobaltate(3-)
- Cas Number:
- 84204-70-6
- Molecular formula:
- C32H20CoN10Na3O14S2
- IUPAC Name:
- trisodium bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-2-hydroxy-5-nitrobenzenesulphonato(3-)]cobaltate(3-)
- Test material form:
- solid: particulate/powder
- Details on test material:
- Environmental fate/Ecotoxicological/Toxicological studies:
Storage: Room temperature, 20-24 °C, in the dark
Stability: pure, for 5 years; in solvent > 24 hours in water, DMSO, DMF, stable for at least 2 hours in aqueous medium.
Evidence of chemical instability at pH 6: none
Safety precaution: routine hygienic procedures were sufficient to assure personnel health and safety.
Toxicological studies:
Preparation: On the day of the experiment, the test article was suspended in Carboxymethylcellulose (1 %).
The vehicle was chosen to its nontoxicity for the animals. All animals received a single standard dose volume of 10 mL/kg body weight orally.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST SYSTEM
Acclimatization March 29 to April 4, 1990
Observation April 5 to April 19, 1990
Source: BRL, Biological Research Laboratories Ltd, Wolferstrasse 4, CH-4414 Fullinsdorf
Number of animals 5 males per group 5 females
Total number of animals 20 males, 20 females
Age at start of treatment males: 10 weeks, females: 12 weeks
Body weight at start males: 235 — 268 g of treatment females: 203-224 g
Identification: By unique cage number and corresponding color coded spots on the tail.
Randomization: Randomly selected at time of delivery in groups of five.
Acclimatization: One week under laboratory conditions, after veterinary examination.
HUSBANDRY
Room No.: 136
Standard Laboratory Conditions:
Air-conditioned with 10-15 air changes per hour, and hourly monitored environment with temperature 22±3 °C, relative humidity 40-70 %, 12 hours artificial fluorescent light/12 hours dark, music/light period.
Accommodation: groups of five in Nakrolon type-3 cages with standard softwood bedding (‘Lignocel’, Schill AG, CH-4132 Muttenz).
Diet: pelleted standard Kliba 343, Batches 67/90 and 68/90 rat maintenance diet (‘Kliba’, Klingentalmuehle AG, CH-4303 Kaiseraugst) available ad libitum.
Analysis for contaminants performed.
Water: community tap water from Itingen, available ad libitum. Analyses for contaminants performed.
Administration / exposure
- Type of coverage:
- semiocclusive
- Vehicle:
- water
- Details on dermal exposure:
- Twenty-four hours after the application, the dressing was removed. The treated skin was washed with lukewarm tap water, dried with disposable paper towels and the skin reaction was assessed according to the method of Noakes and Sanderson (Noakes, D.N. and Sanderson, D.M. A Method for Determining the Dermal Toxicity of Pesticides. Brit. 3. Industr. Med., 26, 59-U, 1969).
- Duration of exposure:
- 24 hours
- Doses:
- Application Volume kg body weight: 4 ml at 2000 mg/kg
- No. of animals per sex per dose:
- 5 males per group 5 females
Total number of animals 20 males, 20 females - Control animals:
- not required
- Details on study design:
- Approximately 24 hours before treatment, the backs of the animals were shaved with an electric clipper, exposing an area of approximately 10 % of the total body surface. On test day 1, the test article was applied evenly on the skin with a syringe and covered with a semi-occlusive dressing. The dressing was wrapped around the abdomen and fixed with an elastic adhesive bandage.
Observations:
Mortality/Viability: Four times during test day 1, and daily during days 2-15.
Clinical Signs: Each animal had an examination for changes in appearance and behaviour four times during day 1, and daily during days 2-15. All abnormalities were recorded. Due to the 24 hour semi-occ1usive treatment, the starting with day 2 of test.
Body Weights: Test days 1 (pre-admnistration), 8 and 15.
Necropsies were performed by experienced prosectors.
All animals were necropsied.
All animals were killed by intraperitoneal injection of sodium pentobarbitone.
GENERAL BEHAVIOUR NOSE
Aggressiveness, vocalization, restlessness/excitation, nervousness, fear sedation, somnolence, sleep-coma
RESPIRATION
Apnea, dyspnea, rales
EYE
Chromodacryorrhea, exophthal mosmiosis, mydriasis whitish discharge, lid adhesion, negative corneal reflex
NOSE
rhinorrhea, epistaxis
MOTILITY
Akinesia, ataxia, dropped head, hyperkinesia, hypokinesia, paralysis, flaccid, paralysis, spastic, paddling movements, stiff gait, rolling movements
BODY POSITION
Ventral body position, latero-abdominal position, hunched posture
MOTOR SUSCEPTIBILITY
spasms, tonic muscle spasms, clonic muscle spasms, opisthotonus, saltatory spasms, trismus, tremor, muscie—twitching, muscle-twitching,
generalized
SKIN
Erythema, edema, necrosis, crusts, scale formations
VARIOUS
Loss of weight, emaciation, diarrhea, ruffled fur, necrosis on appilication AREA, salivation, pallor, cyanosis - Statistics:
- The LOGIT Model could not be applied to the observed rate of death. The toxicity was estimated without use of a statistical model.
Results and discussion
Effect levelsopen allclose all
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- male/female
- Dose descriptor:
- LD0
- Effect level:
- >= 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No death occurred at 2000 mg/kg bw
- Mortality:
- 0 % at 2000 mg/kg
- Clinical signs:
- other: at 2000 mg/kg males/females skin/fur: general erythema (back), scales (back), skin yellow (back). All animals had recovered until termination of the study. Discoloration was observed until termination of test. No systemic symptoms were observed in the an
- Gross pathology:
- at 2000 mg/kg males/females sacrificed : no macroscopical findings noted.
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Conclusions:
- LD50 dermal >2000 mg/kg bw.
- Executive summary:
Materials and methods
The test article was applied to the skin of rats of both sexes for 24 hours at a single dose of 2000 mg/kg.
Observations
The following death rate was observed: 0 % at 2000 mg/kg. Based on these observations, the LOGIT-Model could not be applied to the observed rate of death.
The following local signs were observed: at 2000 mg/kg males/females skin/fur: general erythema (back), scales (back), skin yellow (back).
All animals had recovered until termination of the study. Discoloration was observed until termination of test. No systemic symptoms were observed in the animals throughout the study. The body weight gain of the animals was not affected by the test article treatment throughout the entire study.
The following macroscopical organ findings were observed: at 2000 mg/kg males/females sacrificed : no macroscopical findings noted.
Results
LD50 dermal >2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.